--- title: Buy Gemfibrozil 300mg Pills Online description: Gemfibrozil is a trusted medication for lowering high triglycerides and cholesterol levels. Order 300mg pills from our secure online pharmacy. type: product language: en url: https://liabilis.com/order-gemfibrozil-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 67.44 price_max: 528.99 currency: USD offers: - name: 300mg x 30 pills price: 67.44 - name: 300mg x 60 pills price: 131.09 - name: 300mg x 90 pills price: 197.99 - name: 300mg x 120 pills price: 238.44 - name: 300mg x 180 pills price: 341.99 - name: 300mg x 270 pills price: 528.99 --- # Buy Gemfibrozil 300mg Pills Online Gemfibrozil is a fibrate medication originally developed by Pfizer that helps reduce high triglyceride levels and improve cholesterol profiles. It works by decreasing the liver's production of triglycerides while increasing HDL (good cholesterol) levels. This treatment is designed for adults with hyperlipidemia who need cardiovascular risk management. Our online pharmacy offers reliable access to Gemfibrozil in 300mg pill strength with verified quality assurance. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **300mg** | 30 pills | **$67.44** | $2.23 | In Stock | | **300mg** | 60 pills | **$131.09** | $2.18 | In Stock | | **300mg** | 90 pills | **$197.99** | $2.20 | In Stock | | **300mg** | 120 pills | **$238.44** | $1.99 | In Stock | | **300mg** | 180 pills | **$341.99** | $1.90 | In Stock | | **300mg** | 270 pills | **$528.99** | $1.96 | In Stock | [Buy Now](https://liabilis.com/order-gemfibrozil-online-en.html) ## Introduction Gemfibrozil is a prescription medication used to lower high levels of triglycerides and to modestly raise “good” HDL-cholesterol in the blood. The active ingredient is Gemfibrozil, supplied as a 300 mg oral tablet. It belongs to the fibrate class of lipid-lowering agents. Primary clinical use is for patients with severe hypertriglyceridemia or mixed dyslipidemia, where lowering triglyceride levels reduces the risk of pancreatitis and may improve overall cardiovascular risk. --- ## Quick Reference Facts ``` **Active Ingredient** : Gemfibrozil **Form** : pill 300 mg **Primary Uses** : - Severe hypertriglyceridemia - Mixed dyslipidemia (elevated VLDL + low HDL) - Adjunct therapy for primary hypercholesterolemia when statins alone are insufficient ``` --- ## What is Gemfibrozil? Gemfibrozil is the generic version of medications that contain the active compound Gemfibrozil. It is marketed in many countries under brand names such as **Lopid** and **Lopid-SR**. The drug is manufactured by several licensed pharmaceutical companies and is approved by regulatory agencies including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). As a generic product, Gemfibrozil is bioequivalent to its branded counterparts, delivering the same therapeutic effect at a lower cost. --- ## How Gemfibrozil Works Gemfibrozil belongs to the fibrate family and acts primarily as an agonist of the nuclear receptor peroxisome proliferator-activated receptor-α (PPAR-α). Activation of PPAR-α leads to several metabolic changes: - **Increased lipoprotein lipase (LPL) activity** - LPL hydrolyzes triglyceride-rich very-low-density lipoproteins (VLDL), accelerating clearance of triglycerides from the plasma. - **Reduced hepatic synthesis of VLDL** - By decreasing production of triglyceride-rich particles, circulating triglyceride levels fall. - **Enhanced apolipoprotein A-I and A-II synthesis** - This modestly raises HDL-cholesterol, contributing to reverse cholesterol transport. The net result is a significant drop in fasting and post-prandial triglyceride concentrations, with a smaller increase in HDL-C. Onset of lipid-lowering effect is typically observed within 1-2 weeks, with maximal benefit reached after 4-6 weeks of consistent therapy. Gemfibrozil is metabolised mainly in the liver (via glucuronidation) and eliminated in the urine; its half-life is about 1.5 hours, but pharmacodynamic effects persist due to receptor activation. --- ## Conditions Treated with Gemfibrozil - **Severe hypertriglyceridemia (≥ 500 mg/dL)** High triglyceride levels predispose patients to acute pancreatitis. Gemfibrozil lowers triglycerides by 30-50 %, decreasing this risk. - **Mixed dyslipidemia** In individuals with elevated VLDL and low HDL-C, Gemfibrozil reduces VLDL concentrations and raises HDL-C, improving the overall lipid profile. - **Primary hypercholesterolemia (as adjunct)** When statin therapy alone does not achieve target LDL-C, adding Gemfibrozil can further improve lipid parameters, especially when triglycerides are a dominant abnormality. - **Prevention of pancreatitis secondary to hypertriglyceridemia** Clinical guidelines recommend fibrates, including Gemfibrozil, for patients whose triglyceride levels place them at imminent risk for pancreatic inflammation. --- ## Is Gemfibrozil the Right Medication for You? Gemfibrozil is most appropriate for adults who: - Have fasting triglyceride levels ≥ 500 mg/dL or documented mixed dyslipidemia despite dietary measures. - Are not pregnant, nursing, or planning pregnancy (Gemfibrozil is contraindicated during these periods). - Have adequate hepatic function (baseline liver enzymes ≤ 2-3 × upper-limit normal). Clinical scenarios where Gemfibrozil is frequently prescribed include: - Patients with familial hypertriglyceridemia who have failed lifestyle modification. - Individuals with metabolic syndrome whose triglyceride burden dominates their dyslipidemia profile. Contraindications and cautions: - Active liver disease, biliary obstruction, or gallstones (the drug may exacerbate hepatic lipid accumulation). - Severe renal impairment (creatinine clearance < 30 mL/min) because accumulation increases risk of adverse effects. - Concurrent use with statins, especially high-dose simvastatin, due to a heightened risk of rhabdomyolysis. - Known hypersensitivity to Gemfibrozil or any excipients. Patients with a history of myopathy, uncontrolled hypothyroidism, or those taking cyclosporine, gemfibrozil-sensitive anticoagulants (e.g., warfarin) should discuss alternatives with their clinician. --- ## Buying Gemfibrozil from [our online pharmacy](https://liabilis.com/order-gemfibrozil-online-en.html) ### Why Choose Our Service? Accessing affordable lipid-lowering therapy can be challenging, especially when insurance formularies limit coverage. Our platform provides a discreet, cost-effective way to obtain Gemfibrozil, helping you stay on track with your treatment plan without financial strain. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every shipment undergoes verification against regulatory standards, so you receive a product that matches the original specifications approved by major health agencies. ### Pricing & Access Because Gemfibrozil is available as a generic, our pricing is substantially lower than branded alternatives such as Lopid. This makes long-term therapy more sustainable, particularly for patients who require chronic dosing. ### Discreet Delivery Your privacy matters. Orders are packaged in unmarked, tamper-evident containers and dispatched via express courier (typically within 7 days) or standard airmail (approximately three weeks). Delivery is swift, secure, and completely confidential. --- ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** - The usual adult regimen is 600 mg (two 300 mg tablets) taken twice daily with the main meals. Doses are spaced at least 8 hours apart to maximize triglyceride reduction and minimise gastrointestinal upset. - **Missed dose** - If you remember a missed dose within 4 hours, take it with the next meal. Skip the forgotten dose if it is closer to the time of the next scheduled dose; do not double-dose. - **Overdose** - Symptoms may include nausea, vomiting, abdominal pain, or dizziness. If an overdose is suspected, seek immediate medical attention or contact a Poison Control Center. Treatment is supportive; activated charcoal may be considered if presentation is early. **Practical precautions** - Take Gemfibrozil with food to improve absorption and reduce stomach irritation. - Avoid alcohol, which can potentiate hepatotoxicity. - Do not operate heavy machinery if you feel dizzy or light-headed after the first few doses. --- ## Safety Information ### ⚠️ Who Should Not Take Gemfibrozil - Active liver disease, cholestasis, or unexplained persistent elevation of hepatic transaminases. - Gallbladder disease, including cholelithiasis or biliary obstruction. - Severe renal impairment (creatinine clearance < 30 mL/min). - Pregnant or breastfeeding women. - Known hypersensitivity to Gemfibrozil or any tablet excipients. ### Common Side Effects - **Gastrointestinal:** Dyspepsia, abdominal discomfort, nausea (generally mild and transient). - **Musculoskeletal:** Myalgia or mild muscle cramps; usually resolve with dose adjustment. - **Dermatologic:** Itching or mild rash. - **Laboratory abnormalities:** Slight elevations in liver enzymes or serum creatinine; monitor periodically. ### Serious Side Effects (Seek Immediate Medical Help) - **Rhabdomyolysis:** Severe muscle pain, weakness, dark urine, or marked CK elevation-especially when combined with a statin. - **Hepatotoxicity:** Persistent jaundice, dark urine, or marked ALT/AST rise (> 3 × ULN). - **Allergic reactions:** Swelling of the face, lips, tongue, or difficulty breathing. If any of these occur, discontinue Gemfibrozil and contact a healthcare professional promptly. ### Drug & Food Interactions - **Statins (e.g., simvastatin, lovastatin):** Concomitant use markedly increases myopathy risk; avoid high-dose statins or select agents with lower interaction potential (e.g., pravastatin). - **Anticoagulants (warfarin):** Gemfibrozil can potentiate anticoagulant effect; monitor INR closely. - **Cyclosporine:** Increases Gemfibrozil plasma concentrations; dose adjustment may be required. - **Oral hypoglycemic agents:** May potentiate the glucose-lowering effect of sulfonylureas; monitor blood glucose. - **Alcohol:** Enhances risk of liver toxicity; limit or abstain while on therapy. --- ## Off-Label and Investigational Uses of Gemfibrozil - **Secondary prevention of cardiovascular events** - Some cohort studies have suggested that fibrates, including Gemfibrozil, may reduce the incidence of non-fatal myocardial infarction in patients with atherogenic dyslipidemia, though large randomized trials have produced mixed results. - **Adjunct treatment in type 2 diabetes** - Limited data indicate modest reductions in fasting triglycerides and potential improvement in insulin sensitivity when used alongside standard antidiabetic therapy. These uses remain investigational and should only be considered under specialist supervision. All off-label applications lack formal regulatory approval; their safety and efficacy have not been definitively established. --- ## Storage & Handling - Store tablets at **20-25 °C (68-77 °F)**; excursions permitted between 15-30 °C. - Keep the container tightly closed, protected from moisture and direct sunlight. - Do not use tablets after the printed expiration date. - Dispose of unused medication according to local pharmacist or hazardous-waste guidelines; do not flush. --- ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Gemfibrozil?** Yes, but keep the medication in its original labeled container, carry a copy of the prescription, and be aware of the import regulations of the destination country. - **Should I take Gemfibrozil at the same time each day?** Consistency improves efficacy. Taking it with each main meal (breakfast and dinner) is recommended to maintain steady plasma levels. - **Does grapefruit juice affect Gemfibrozil?** Gemfibrozil is not significantly metabolised by CYP3A4, so grapefruit juice does not produce a clinically relevant interaction. **Product & Formulation Details** - **What do Gemfibrozil tablets look like?** The generic 300 mg tablets are usually white, round, and biconvex, embossed with “300” on one side and the manufacturer’s logo on the other. Appearance may vary slightly between suppliers. - **Can the tablets be split or crushed?** Gemfibrozil tablets are not formulated for extended-release; they can be split if a lower dose is required, but crushing is unnecessary and may affect taste. **Regulatory & Safety Nuances** - **Will Gemfibrozil show up on a standard drug test?** Gemfibrozil is not screened for in typical occupational or athletic drug-testing panels because it is not a performance-enhancing or illicit substance. - **Is Gemfibrozil safe for older adults?** Elderly patients may have reduced renal clearance and a higher risk of myopathy, especially when combined with statins. Dose adjustments and close monitoring are advised. **Scientific & Clinical Curiosity** - **When was Gemfibrozil first approved?** The U.S. FDA approved Gemfibrozil for hyperlipidaemia in the early 198s, following clinical trials that demonstrated its triglyceride-lowering efficacy. - **How does Gemfibrozil differ from other fibrates like fenofibrate?** Both activate PPAR-α, but Gemfibrozil has a shorter half-life and a higher propensity for drug-drug interactions with statins, whereas fenofibrate offers a once-daily dosing schedule and a different metabolic profile. --- ## Glossary **PPAR-α (Peroxisome Proliferator-Activated Receptor-α)** : A nuclear receptor that regulates genes involved in lipid metabolism; activation lowers triglycerides and raises HDL-C. **Rhabdomyolysis** : A severe breakdown of skeletal muscle tissue that releases muscle cell contents into the bloodstream, potentially causing kidney damage. **Hypertriglyceridemia** : An abnormally high concentration of triglycerides in the blood, often defined as > 150 mg/dL; severe levels (> 500 mg/dL) increase pancreatitis risk. --- ## Disclaimer The information presented about **Gemfibrozil** is intended for general educational purposes and does not replace personalized medical advice. Treatment decisions, including any off-label applications, should be made under the direct supervision of a qualified healthcare professional. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://liabilis.com/order-gemfibrozil-online-en.html) provides access to **Gemfibrozil** for individuals who may encounter limited availability through conventional pharmacies, insurance-based dispensing, or who seek cost-effective generic alternatives. Always discuss with your physician before initiating, modifying, or discontinuing any medication.